Aware (AWRE) 10-Q 24 Apr 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 20, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	AWARE INC /MA/
Entity Central Index Key	1015739
Trading Symbol	awre
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		22,865,565
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

CONSOLIDATED_BALANCE_SHEETS_un

CONSOLIDATED BALANCE SHEETS (unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$44,685	$43,985
Accounts receivable, net	3,251	3,619
Inventories	2	2
Deferred tax assets	187	168
Prepaid expenses and other current assets	915	401
Total current assets	49,040	48,175
Property and equipment, net	5,195	5,289
Investments	925	1,428
Long term deferred tax assets	600	804
Other assets	480	197
Total assets	56,240	55,893
Current liabilities:
Accounts payable	191	258
Accrued expenses	833	820
Deferred revenue	1,952	2,352
Total current liabilities	2,976	3,430
Long-term deferred revenue	79	74
Commitments and contingent liabilities
Stockholders' equity:
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding
Common stock, $.01 par value; 70,000,000 shares authorized; issued and outstanding 22,865,565 as of March 31, 2015 and 22,808,761 as of December 31, 2014	229	228
Additional paid-in capital	104,271	103,756
Accumulated other comprehensive loss	-21	-29
Accumulated deficit	-51,294	-51,566
Total stockholders' equity	53,185	52,389
Total liabilities and stockholders' equity	$56,240	$55,893

CONSOLIDATED_BALANCE_SHEETS_un1

CONSOLIDATED BALANCE SHEETS (unaudited) (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement Of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$1	$1
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares outstanding
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	22,865,565	22,808,761
Common stock, shares outstanding	22,865,565	22,808,761

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenue:
Software licenses	$1,649	$1,617
Software maintenance	1,153	1,045
Services	1,220	1,008
Hardware		2,633
Royalties	101	314
Total revenue	4,123	6,617
Costs and expenses:
Cost of hardware		1,902
Cost of services	547	463
Research and development	1,435	1,279
Selling and marketing	972	858
General and administrative	785	804
Total costs and expenses	3,739	5,306
Operating income	384	1,311
Other income	12
Interest income	41	86
Income before provision for income taxes	437	1,397
Provision for income taxes	165	517
Net income	272	880
Net income per share - basic	$0.01	$0.04
Net income per share - diluted	$0.01	$0.04
Weighted-average shares - basic	22,866	22,626
Weighted-average shares - diluted	22,887	22,699
Comprehensive income:
Net income	272	880
Other comprehensive income (net of tax):
Unrealized gains on available for sale securities	8	84
Comprehensive income	$280	$964

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income	$272	$880
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	145	132
Stock-based compensation	21	29
Deferred tax provision on other comprehensive income	-4	-60
Gain on sale of investments	-12
Amortization of premium/(discount) on investments	-2	2
Changes in assets and liabilities:
Accounts receivable	368	-11
Inventories		1,600
Prepaid expenses and other current assets	-514	-82
Deferred tax assets	185	89
Accounts payable	-67	-1,311
Accrued expenses	13	-56
Deferred revenue	-395	-4
Net cash provided by operating activities	10	1,208
Cash flows from investing activities:
Purchases of property and equipment	-14	-11
Sales of investments	529
Purchase of other assets	-320
Net cash provided by (used in) investing activities	195	-11
Cash flows from financing activities:
Proceeds from issuance of common stock		9
Excess tax benefits from stock-based compensation	582	594
Payments made for taxes of employees who surrendered shares related to unrestricted stock	-87	-92
Net cash provided by financing activities	495	511
Increase in cash and cash equivalents	700	1,708
Cash and cash equivalents, beginning of period	43,985	72,660
Cash and cash equivalents, end of period	44,685	74,368
Supplemental disclosure:
Cash paid for income taxes	$5	$2

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Basis Of Accounting [Abstract]
Basis of Presentation	A)	Basis of Presentation. The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and therefore do not include all information and notes necessary for a complete presentation of our financial position, results of operations and cash flows, in conformity with generally accepted accounting principles.  We filed audited financial statements which included all information and notes necessary for such presentation for the three years ended December 31, 2014 in conjunction with our 2014 Annual Report on Form 10-K. This Form 10-Q should be read in conjunction with that Form 10-K.
	The accompanying unaudited consolidated balance sheets, statements of income and comprehensive income, and statements of cash flows reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at March 31, 2015, and of operations and cash flows for the interim periods ended March 31, 2015 and 2014.
	The results of operations for the interim period ended March 31, 2015 are not necessarily indicative of the results to be expected for the year.

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurements	B)	Fair Value Measurements. The Financial Accounting Standards Board (“FASB”) Codification defines fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to the unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable.
	Cash and cash equivalents, which primarily include money market mutual funds, were $44.7 million and $44.0 million as of March 31, 2015 and December 31, 2014, respectively. We classified our cash equivalents of $34.9 million and $34.3 million as of March 31, 2015 and December 31, 2014 within Level 1 of the fair value hierarchy because they are valued using quoted market prices.
	Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. We categorize our investments as available-for-sale securities, and carry them at fair value in our financial statements.  We had $0.9 million and $1.4 million of available-for-sale investments as of March 31, 2015 and December 31, 2014, respectively.
	As of March 31, 2015, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):
			Fair Value Measurement at March 31, 2015 Using:
			Quoted Prices in		Significant Other		Significant
			Active Markets for		Observable Inputs		Unobservable
			Identical Assets				Inputs
			(Level 1)		(Level 2)		(Level 3)
	Corporate debt securities		$	925	$	-	$	-
	Money market funds (included in cash and cash equivalents)			34,930
	Total		$	35,855	$	-	$	-
	As of December 31, 2014, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):
			Fair Value Measurement at December 31, 2014 Using:
			Quoted Prices in		Significant Other		Significant
			Active Markets for		Observable Inputs		Unobservable
			Identical Assets				Inputs
			(Level 1)		(Level 2)		(Level 3)
	Corporate debt securities		$	1,428	$	-	$	-
	Money market funds (included in cash and cash equivalents)			34,339
	Total		$	35,767	$	-	$	-

Inventories

Inventories	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Inventories	C)	Inventories. Inventories are stated at the lower of cost or net realizable value with cost being determined by the first-in, first-out (“FIFO”) method.  Inventories consisted of the following (in thousands):
			March 31,		December 31,
			2015		2014
	Raw materials		$	2	$	2
	Finished goods			-		-
	Total		$	2	$	2

Computation_of_Earnings_per_Sh

Computation of Earnings per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Computation of Earnings per Share	D)	Computation of Earnings per Share. Basic earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding.  Diluted earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued.  For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect.  Stock options that are anti-dilutive are excluded from the calculation.
	Net income per share is calculated as follows (in thousands, except per share data):
			Three Months Ended
			March 31,
			2015		2014
	Net income		$	272	$	880
	Weighted average common shares outstanding			22,866		22,626
	Additional dilutive common stock equivalents			21		73
	Diluted shares outstanding			22,887		22,699
	Net income per share – basic		$	0.01	$	0.04
	Net income per share – diluted		$	0.01	$	0.04
	For the three month periods ended March 31, 2015 and 2014, options to purchase 54,034 and 821,838 shares of common stock were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive.

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2015
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Stock-Based Compensation	E)	Stock-Based Compensation.  The following table presents stock-based employee compensation expenses included in our unaudited consolidated statements of comprehensive income (in thousands):
			Three Months Ended
			March 31,
			2015		2014
	Cost of services		$	1	$	1
	Research and development			2		2
	Selling and marketing			-		1
	General and administrative operations			18		25
	Stock-based compensation expense		$	21	$	29
	Stock Option Grants. We may grant stock options under our 2001 Nonqualified Stock Plan although we have not granted any stock options since the first quarter of 2012. When we grant stock options, we estimate their fair value using the Black-Scholes valuation model. This valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions. The assumptions used to estimate the fair value of stock options include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield. We believe that the valuation technique and the approach utilized to develop the underlying assumptions are appropriate in calculating the fair values of our stock options. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards.
	Unrestricted Stock Grants. We also grant unrestricted shares of stock under our 2001 Nonqualified Stock Plan. Stock-based compensation expense for stock grants is determined based on the fair market value of our stock on the date of grant, provided the number of shares in the grant is fixed on the grant date.
	We granted shares of unrestricted stock in 2015 and 2014 that affected financial results for the three month periods ended March 31, 2015 and 2014. These grants are described below.
	2015 Grant. On March 26, 2015, we granted 152,000 shares of unrestricted stock to directors, officers and employees. The shares will be issued in two equal installments shortly after June 30, 2015 and December 31, 2015, provided each grantee is serving as a director, officer or employee on those dates. The total stock-based compensation expense related to this grant is $682,000, of which $15,000 was charged to expense in the three months ended March 31, 2015 and we anticipate the remaining $667,000 will be charged to expense ratably over the remaining three quarters of 2015.
	2014 Grant.  In March 2014, we granted 152,000 shares of unrestricted stock to directors, officers and employees. The shares were issued in two equal installments shortly after June 30, 2014 and December 31, 2014. We expensed the entire $876,000 stock-based compensation expense related to this grant in 2014. We issued shares of common stock related to this grant as follows: i) 58,769 net shares of common stock were issued in early July 2014 after employees surrendered 17,231 shares for which we paid $113,000 of withholding taxes on their behalf; and ii) 56,804 net shares of common stock were issued in early January 2015 after employees surrendered 19,196 shares for which we paid $87,000 of withholding taxes on their behalf.

Business_Segments

Business Segments	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Business Segments	F)	Business Segments. We organize ourselves into a single segment that reports to the chief operating decision makers.
	We conduct our operations in the United States and sell our products and services to domestic and international customers.  Revenues were generated from the following geographic regions for the three months ended March 31, 2015 and 2014 (in thousands):
			Three Months Ended
			March 31,
			2015		2014
	United States		$	2,488	$	5,496
	Brazil			726		39
	Rest of world			909		1,082
			$	4,123	$	6,617
	Revenue by product group for the three months ended March 31, 2015 and 2014 was (in thousands):
			Three Months Ended
			March 31,
			2015		2014
	Biometrics		$	3,849	$	6,181
	Imaging			173		122
	DSL royalties			101		314
			$	4,123	$	6,617

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2015
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	G)	Recent Accounting Pronouncements.  In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU is the result of a joint project by the FASB and the International Accounting Standards Board (“IASB”) to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that would: remove inconsistencies and weaknesses, provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices across entities, jurisdictions, industries, and capital markets, improve disclosure requirements and resulting financial statements, and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2016.  Early adoption is not permitted. On April 1, 2015, the FASB voted to propose a deferral of the effective date of the new revenue standard by one year, but to permit entities to adopt one year earlier if they choose (i.e., the original effective date). We are currently evaluating the effect that the updated standard will have on our consolidated financial statements and related disclosures.
	With the exception of the new revenue standard discussed above, there have been no other recently issued accounting pronouncements that are of significance or potential significance to us that we have not adopted as of March 31, 2015.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	H)	Income Taxes.  Income tax expense was $0.2 million and $0.5 million for the three months ended March 31, 2015 and 2014, respectively. Income tax expense in the three month periods of 2015 and 2014 was based on the U.S. statutory rate of 34%, increased by state income taxes.
		In the three month period ended March 31, 2015, we utilized deferred tax assets to reduce our tax liability payable to the government.  A portion of the deferred tax assets we used comprised cumulative deductions for stock options in excess of book expense. Under income tax accounting rules, that portion of tax benefits attributable to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. The tax benefits from such stock-based awards were $0.6 million in the three month period ended March 31, 2015. These tax benefits were recorded as an equity adjustment to additional paid-in capital.
	As of March 31, 2015, we had a total of $0.8 million of deferred tax assets for which we had recorded no valuation allowance.  We will continue to assess the level of valuation allowance in future periods.  Should evidence regarding the realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly.
	In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and development credit carryforwards available at December 31, 2014 of $4.0 million and $0.3 million. These credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to reduce our tax liability. To the extent that these assets are used to reduce future taxes, the benefit will be recorded as a reduction to additional paid-in capital. The aforementioned $0.6 million equity adjustment to additional paid-in capital in the three month period ended March 31, 2015 was related to these deferred tax assets.
	The Internal Revenue Service commenced an examination of our tax return for the year ended December 31, 2012 in September 2014.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Accumulated Other Comprehensive Loss	I)	Accumulated Other Comprehensive Loss. The components of accumulated other comprehensive loss and activity were as follows (in thousands):
			December 31,			Increase/			Reclassification				March 31,
			2014			Decrease			Adjustments				2015
	Unrealized losses on available for sale securities		($	87	)	$	13		$	-			($	74	)
	Unrealized gains on available for sale securities			43			(13	)		12				42
	Net unrealized gains (losses) on available for sale securities			(44	)		-			12		(a)		(32	)
	Income tax benefit (expense) on other comprehensive loss			15			-			(4	)			11
	Total accumulated other comprehensive loss, net of taxes		($	29	)	$	-		$	8			($	21	)
	(a)	– Classified in other income.

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Schedule of assets measured at fair value on a recurring basis		Fair Value Measurement at March 31, 2015 Using:
		Quoted Prices in		Significant Other		Significant
		Active Markets for		Observable Inputs		Unobservable
		Identical Assets				Inputs
		(Level 1)		(Level 2)		(Level 3)
	Corporate debt securities	$	925	$	-	$	-
	Money market funds (included in cash and cash equivalents)		34,930
	Total	$	35,855	$	-	$	-
		Fair Value Measurement at December 31, 2014 Using:
		Quoted Prices in		Significant Other		Significant
		Active Markets for		Observable Inputs		Unobservable
		Identical Assets				Inputs
		(Level 1)		(Level 2)		(Level 3)
	Corporate debt securities	$	1,428	$	-	$	-
	Money market funds (included in cash and cash equivalents)		34,339
	Total	$	35,767	$	-	$	-

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Schedule of inventories		March 31,		December 31,
		2015		2014
	Raw materials	$	2	$	2
	Finished goods		-		-
	Total	$	2	$	2

Computation_of_Earnings_per_Sh1

Computation of Earnings per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule of net income per share		Three Months Ended
		March 31,
		2015		2014
	Net income	$	272	$	880
	Weighted average common shares outstanding		22,866		22,626
	Additional dilutive common stock equivalents		21		73
	Diluted shares outstanding		22,887		22,699
	Net income per share – basic	$	0.01	$	0.04
	Net income per share – diluted	$	0.01	$	0.04

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Schedule of stock-based employee compensation expense included in unaudited consolidated statements of comprehensive income
		Three Months Ended
		March 31,
		2015		2014
	Cost of services	$	1	$	1
	Research and development		2		2
	Selling and marketing		-		1
	General and administrative operations		18		25
	Stock-based compensation expense	$	21	$	29

Business_Segments_Tables

Business Segments (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of revenues generated from geographic regions		Three Months Ended
			March 31,
			2015		2014
	United States		$	2,488	$	5,496
	Brazil			726		39
	Rest of world			909		1,082
			$	4,123	$	6,617
Schedule of revenue by product group			Three Months Ended
			March 31,
			2015		2014
	Biometrics		$	3,849	$	6,181
	Imaging			173		122
	DSL royalties			101		314
			$	4,123	$	6,617

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Schedule of components of accumulated other comprehensive loss and activity
			December 31,			Increase/			Reclassification				March 31,
			2014			Decrease			Adjustments				2015
	Unrealized losses on available for sale securities		($	87	)	$	13		$	-			($	74	)
	Unrealized gains on available for sale securities			43			(13	)		12				42
	Net unrealized gains (losses) on available for sale securities			(44	)		-			12		(a)		(32	)
	Income tax benefit (expense) on other comprehensive loss			15			-			(4	)			11
	Total accumulated other comprehensive loss, net of taxes		($	29	)	$	-		$	8			($	21	)
	(a)	– Classified in other income.

Fair_Value_Measurements_Assets

Fair Value Measurements - Assets measured at fair value on a recurring basis (Details) (Fair value on recurring basis, USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	$35,855	$35,767
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate debt securities	925	1,428
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds (included in cash and cash equivalents)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds (included in cash and cash equivalents)	34,930	34,339
Fair Value Measurement, Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate debt securities
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Money market funds (included in cash and cash equivalents)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds (included in cash and cash equivalents)
Fair Value Measurement, Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate debt securities
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Money market funds (included in cash and cash equivalents)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds (included in cash and cash equivalents)

Fair_Value_Measurements_Detail

Fair Value Measurements (Detail Textuals) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, primarily include money market funds	$44,685	$43,985	$74,368	$72,660
Fair value on recurring basis | Corporate debt securities | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale investments	925	1,428
Fair value on recurring basis | Money market funds (included in cash and cash equivalents) | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, primarily include money market funds	$34,900	$34,300

Inventories_Summary_of_invento

Inventories - Summary of inventories (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]
Raw materials	$2	$2
Finished goods
Total	$2	$2

Computation_of_Earnings_per_Sh2

Computation of Earnings per Share - Summary of net income per share (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Net income	$272	$880
Weighted average common shares outstanding (in shares)	22,866	22,626
Additional dilutive common stock equivalents (in shares)	21	73
Diluted shares outstanding (in shares)	22,887	22,699
Net income per share - basic	$0.01	$0.04
Net income per share - diluted	$0.01	$0.04

Computation_of_Earnings_per_Sh3

Computation of Earnings per Share (Detail Textuals) (Options)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock Share purchase (in shares)	54,034	821,838

StockBased_Compensation_Summar

Stock-Based Compensation - Summary of stock-based employee compensation expenses (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$21	$29
Cost of services
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	1	1
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	2	2
Selling and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation		1
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$18	$25

StockBased_Compensation_Detail

Stock-Based Compensation (Detail Textuals) (Unrestricted Stock Grants, 2001 Nonqualified Stock Plan, Directors, officers and employees, USD $)	0 Months Ended	1 Months Ended		12 Months Ended	1 Months Ended	3 Months Ended
	Jul. 01, 2014	Jan. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Mar. 26, 2015	Mar. 31, 2015
2014 Grant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted (in shares)			152,000
Stock-based compensation expense				$876,000
Number of shares issued (in shares)	58,769	56,804
Number of common stock shares surrendered by employees withholding taxes	17,231	19,196
Common stock value surrendered by employees withholding taxes	113,000	87,000
2015 Grant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted (in shares)					152,000
Stock-based compensation expense						682,000
Stock based compensation expense charged						15,000
Remaining stock based compensation expense						$667,000

Business_Segments_Revenues_gen

Business Segments - Revenues generated following geographic regions (Details ) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting Information [Line Items]
Revenue:	$4,123	$6,617
Operating Segments | United States
Segment Reporting Information [Line Items]
Revenue:	2,488	5,496
Operating Segments | Brazil
Segment Reporting Information [Line Items]
Revenue:	726	39
Operating Segments | Rest of World
Segment Reporting Information [Line Items]
Revenue:	$909	$1,082

Business_Segments_Summary_of_r

Business Segments - Summary of revenue by product group (Details 1) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting Information [Line Items]
Revenue:	$4,123	$6,617
Operating Segments | Biometrics
Segment Reporting Information [Line Items]
Revenue:	3,849	6,181
Operating Segments | Imaging
Segment Reporting Information [Line Items]
Revenue:	173	122
Operating Segments | DSL royalties
Segment Reporting Information [Line Items]
Revenue:	$101	$314

Income_Taxes_Detail_Textuals

Income Taxes (Detail Textuals) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Operating Loss Carryforwards [Line Items]
Income tax expense	$165,000	$517,000
Income tax U.S. statutory rate	34.00%	34.00%
Tax benefits from stock-based awards	600,000
Deferred tax assets	800,000
Equity adjustment to additional paid-in capital	600,000
Federal | Research and development credit carryforwards
Operating Loss Carryforwards [Line Items]
Net federal and state research and development credit carryforwards			4,000,000
State | Research and development credit carryforwards
Operating Loss Carryforwards [Line Items]
Net federal and state research and development credit carryforwards			$300,000

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss - Components of accumulated other comprehensive loss and activity (Details 1) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities	($44)
Beginning balance Income tax benefit (expense) on other comprehensive loss	15
Beginning balance Total accumulated other comprehensive loss, net of taxes	-29
Increase/Decrease Net unrealized gains (losses) on available for sale securities
Increase/Decrease Income tax benefit (expense) on other comprehensive loss
Increase/Decrease Total accumulated other comprehensive loss, net of taxes
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities	12	[1]
Reclassification Adjustments Income tax benefit (expense) on other comprehensive loss	-4
Reclassification Adjustments Total accumulated other comprehensive loss, net of taxes	8
Ending balance Net unrealized gains (losses) on available for sale securities	-32
Ending balance Income tax benefit (expense) on other comprehensive loss	11
Ending balance Total accumulated other comprehensive loss, net of taxes	-21
Unrealized losses on available for sale securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities	-87
Increase/Decrease Net unrealized gains (losses) on available for sale securities	13
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities
Ending balance Net unrealized gains (losses) on available for sale securities	-74
Unrealized gains on available for sale securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities	43
Increase/Decrease Net unrealized gains (losses) on available for sale securities	-13
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities	12
Ending balance Net unrealized gains (losses) on available for sale securities	$42
[1]	Classified in other income.